Oregon Prescription Drug Monitoring Program

Slides:



Advertisements
Similar presentations
Preventing Prescription Drug Abuse: Laws and Legislation Hollie Hendrikson, MSc Policy Specialist, Health Program.
Advertisements

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
Project Lazarus/CCNC A statewide initiative to prevent drug overdose Dr. Robin Gary Cummings Deputy Secretary for Health Services State Health Director.
Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
Maine’s Prescription Monitoring Program Maine Benzodiazepine Study Group Conference 2007 UPDATE Daniel J. Eccher, MPH Project Coordinator.
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
FUNDING OPPORTUNITIES. BACKGROUND New category of funding in the FY13 Harold Rogers Prescription Drug Monitoring Program Official title is “Category 3:
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.
Oregon Prescription Drug Monitoring Program A new program to help Healthcare Providers give better care.
Maine’s Prescription Monitoring Program Daniel J. Eccher, MPH Project Coordinator Prescription Drug Misuse: A Community Challenge.
Reducing Preventable Emergency Room Visits 1. An Opportunity Redirecting care to the most appropriate setting protects patient safety and ensures payment.
1 Prescribing Pain Medication – Guidelines for the Emergency Department April 22, 2012 Jennifer Sabel, PhD.
Barnstable County Regional Substance Abuse Council Updated October 2015 Barnstable County Department of Human Services |
ASTHO Prescription Drug Misuse and Abuse Strategic Map:
SCRIPTS South Carolina Reporting & Identification Prescription Tracking System.
Lindsey Browning Senior Policy Associate, NAMD Medicaid and Prescription Drug Abuse Medicaid National Meeting on Prescription Drug Abuse and Overdose February.
Nebraska’s Prescription Drug Monitoring Program What Do I Really Need to Know? Amy Reynoldson, DHHS Kevin C. Borcher, PharmD,NeHII, Inc.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.
ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)
THE MANY FACES OF THE OPIOD EPIDEMIC
State Targeted Response to Opioid Crisis
Wireless Access SSID: cwag2017
OPIOID EPIDEMIC.
Wireless Access SSID: cwag2017
Illinois’ 1115 Behavioral Health Transformation Waiver
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
New NC Medical Board Opioid Prescribing CME Requirements
THE OPIOID CRISIS Mississippi Board of Nursing
Nebraska Prescription Drug Overdose Prevention Program Efforts
Drug Diversion and Substance Use Disorder Management: Optimizing Collaboration Across the Continuum Michael O’Neil, Pharm.D. Professor and Chair, Department.
Caldwell County Narcotic Initiative
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Opioids – A Pharmaceutical Perspective on Prescription Drugs
An Overview of the ePDMP
Statewide Epidemiological Outcomes Workgroup
Addiction and the Opioid Crisis: HHS Update
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
A State Targeted Response to the Opioid Crisis:
Key Performance Indicators
MDHHS Response to the Opioid Crisis
Managing the Opioid Epidemic in Louisiana Together We Can
Barbara Allison-Bryan, MD
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Opioids in Butte County
Prescription Drug Monitoring Program
Oregon Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
Pain Management and Substance Use Disorders: JCPP Strategic Session
Jim Langford – Georgia Prevention Project November 5, 2018
Oregon’s Opioid Initiative: How Hospice & Palliative Care Can Help
NJ Cares Initiatives Impact on Municipalities
2019 Medicare Part D Rule Opioid-related Provisions
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Prescription Drug Monitoring Program
Illinois Prescription Monitoring Program
collaboration giving community 2018 HOUSTON OPIOID SUMMIT
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Community-Based Strategies for Preventing Opioid Abuse
Strategic Initiatives to Address Opioid Overdose & Addiction
The Silent Killer in America
PMP Advisory Committee
Presentation transcript:

Oregon Prescription Drug Monitoring Program Lisa Millet, Section Manager Oregon Prescription Drug Monitoring Program Injury and Violence Prevention Section, Public Health Division Roseburg Opioid Summit, Umpqua Community College, March 21, 2017

Overview How PDMP can help, PDMP registration, and operation Use of de-identified aggregated PDMP data for policy, practice and evaluation Use of de-identified aggregated PDMP data for research Oregon Prescription Drug Monitoring Program Injury and Violence Prevention Section Oregon Public Health Division

How PDMPs Can Help Support medically necessary uses of controlled substances Identify risks to patient safety Facilitate coordination of care among providers Aid in the identification of potential misuse, abuse, or diversion of prescription drugs Assist in initiating compassionate conversations Help the intervention and treatment of people addicted to prescription drugs Help provide safer and more effective pain management for persons with chronic pain and limit risky prescribing to opioid naive Oregon Prescription Drug Monitoring Program Injury and Violence Prevention Section Oregon Public Health Division

Oregon Law Allows the PDMP to Provide Retail Prescription Data to Prescribers (MD, DO, NP, PA) Pharmacists Delegates (non-licensed staff of prescribers and pharmacists) Licensing Boards Patients Medical Examiners Law enforcement (with a court order) Evaluation and research Oregon Prescription Drug Monitoring Program Injury and Violence Prevention Section Oregon Public Health Division

Using the PDMP Registration starts online with a second step of printing out a registration form and sending it to the PDMP office Authorized account holders - prescribers and pharmacists (or their delegates) can query a 3 year prescription history of their patients Can also query their DEA number to see all prescriptions filled under that number Patients can request their own prescription history Oregon Prescription Drug Monitoring Program Injury and Violence Prevention Section Oregon Public Health Division

Contact Information for PDMP Operations Password resets and general help desk (866) 205-1222 Orpdmp-info@hidinc.com Prescription Drug Monitoring Program (971) 673-0741 Pdmp.health@state.or.us Oregon Prescription Drug Monitoring Program Injury and Violence Prevention Section, Oregon Public Health Division

Use of Aggregated De-Identified PDMP Data Prescription Drug Overdose Prevention Grant Create a “data dashboard” to VISUALIZE data Displays prescribing trends and overdose outcomes At the county, region and state levels Interactive Publically available Useful for grantee regions and public Embed on our website

The Dashboard https://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/data.aspx Healthoregon.org/opioids and look for the “Data Dashboard” link on the left Tabs to navigate for deeper looks at prescribing, hospitalization, death, and technical notes Scroll down for statewide hospitalization and death data

Statewide Measures – Prescribing (PDMP) https://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/data.aspx

County Measures – Prescribing (PDMP) Benzodiazepine Prescribing Opioid Prescribing https://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/data.aspx

County Measures – Prescribing (PDMP) High Dose Opioid Prescribing (>120 MED from single dose) Opioid Prescribing https://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/data.aspx

County Measures – Prescribing (PDMP) High Dose Opioid Prescribing (>120 MED from single dose) Opioid Prescribing Age Group https://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/data.aspx

Statewide Measures – Hospitalization and Death https://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/data.aspx

County Measures – Hospitalizations Any Opioid Hospitalization by County Any Opioid Hospitalization by Age https://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/data.aspx

Research Using De-Identified PDMP Data, 2016 Josh Van Otterloo, MPH, PDMP Research Analyst And Researchers at HealthInsight, OSU and OHSU

(Clackamas, Multnomah, Washington) County Requests Counties wanting to understand prescribing in their area Central Oregon Health Council (Crook, Deschutes, Jefferson) Metro Counties (Clackamas, Multnomah, Washington)

OSU School of Pharmacy – Medicaid - Takeaways Quantifies the amount of opioid fills dispensed to the Medicaid population that aren’t in the claims database (~13%) Long acting opioids are more commonly paid out of pocket Risky prescribing practices associated with cash payment Only analyzing claims data to evaluate policy (such as prior authorization) overstates the impact of the policy

Acumentra / HealthInsight – Rick Deyo Takeaways ~5% of opioid initiators became long term users Initial prescribing characteristics associated with long term use Number of fills Dose Long-acting opioids Suggests initiation with a single fill, low dose, short acting opioid Supports CDC guideline

Acumentra / HealthInsight – Peter Geissert - Takeaways Proactive alerts using only PDMP variables are going to have a low PPV and need to be carefully formulated so to avoid “alert fatigue”

Summary Coordinating community efforts will reduce drug overdose, misuse, substance use disorder, diversion, and improve pain care. Risk reduction is an important public health goal. Government + Private Sector + Community partnership focused on simultaneous implementation of key strategies will result in improved outcomes for patients, communities, and provide a return on investments made to address this multifaceted problem Key strategies: implement prescribing guidelines, ensure access to MAT, expanding chronic pain care options, nalxone rescue This is a winnable battle – we are: saving lives, improving pain care, patient safety & community safety, and we can create a bridge to recovery for those that need it

Contact Lisa Millet, MSH Injury and Violence Prevention Program Director Oregon Public Health Division Oregon Health Authority PH: 503.572.8585 Email: Lisa.M.Millet@state.or.us http://public.health.oregon.gov/PreventionWellness/SubstanceUse/Opioids/Pages/index.aspx